A look at the new filings & IPOs that updated terms over the last seven days. <\/p>\n
NEW FILINGS<\/span> Company: Spruce Biosciences, Inc. Company: Kronos Bio, Inc. Company: Shattuck Labs, Inc. Company: Array Technologies, Inc. Company: MINISO Group Holding Limited Company: Spinal Elements Holdings, Inc. Company: Opthea Limited TERMS ADDED<\/strong><\/span><\/p>\n Company: Immunome Inc. Company: Lixiang Education Holding Co., Ltd. Company: Pulmonx Corporation Company: Chindata Group Holdings Limited Company: Academy Sports and Outdoors, Inc. Company: Yalla Group Limited Company: Boqii Holding Limited Company: Mission Produce, Inc. A look at the new filings & IPOs that updated terms over the last seven days.<\/p>\n","protected":false},"author":4,"featured_media":12986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,2058,1536],"tags":[],"class_list":["post-15086","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=15086"}],"version-history":[{"count":4,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15086\/revisions"}],"predecessor-version":[{"id":15090,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15086\/revisions\/15090"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/12986"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=15086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=15086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=15086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong><\/p>\n
\nSymbol: SPRB
\nDescription: They are a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Cowen, SVB Leerink, Credit Suisse, RBC Capital
\nFiled:9-18-20
\nListed Cash Raise: $86.25m<\/p>\n
\nSymbol: KRON
\nDescription: They are a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, Jefferies, Cowen, Piper Sandler
\nFiled: 9-18-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: STTK
\nDescription: They are an innovative clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, Cowen, Evercore ISI
\nCo-Manager(s): Needham & Company
\nFiled: 9-18-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: ARRY
\nDescription: They are one of the world\u2019s largest manufacturers of ground-mounting systems used in solar energy projects.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, J.P. Morgan, Guggenheim Securities, Morgan Stanley, Credit Suisse, Barclays, UBS Investment Bank
\nFiled: 9-22-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: MNSO
\nDescription: They are a fast-growing global value retailer offering a variety of design-led lifestyle products.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, BofA Securities
\nFiled: 9-23-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: SPEL
\nDescription: They are a medical device company focused on the design, development and commercialization of a comprehensive portfolio of systems, products and technologies for spine surgery procedures, with a strategic focus on minimally invasive surgery (\u201cMIS\u201d) procedures.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Credit Suisse, Baird, Stifel
\nCo-Manager(s): Truist Securities, BTIG, Siebert Williams Shank
\nFiled: 9-23-20
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: OPT
\nDescription: They are a clinical stage biopharmaceutical company developing a novel therapy for the treatment of highly prevalent and progressive retinal diseases
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Citigroup, SVB Leerink
\nCo-Manager(s): Truist Securities, Oppenheimer & Co
\nFiled: 9-24-20
\nListed Cash Raise: $150m<\/p>\n
\nSymbol: IMNM
\nDescription: They are a biopharmaceutical company utilizing our proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated.
\nShares: 2.5 million
\nPrice Range: $11.00-$13.00
\nMarket Cap: $102m-$121m
\nTrade Date: TBD
\nUnderwriter(s): Ladenburg Thalmann, Chardan
\nTerms Added: 9-24-20<\/p>\n
\nSymbol: LXEH
\nDescription: They are a prominent private primary and secondary education service provider in Lishui City, Zhejiang Province.
\nShares: 3.33 million ADSs
\nPrice Range: $9.00-$11.00
\nMarket Cap: $120m-$147m
\nTrade Date: TBD
\nUnderwriter(s): AMTD
\nCo-Manager: Loop Capital
\nTerms Added: 9-24-20<\/p>\n
\nSymbol: LUNG
\nDescription: They are a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD).
\nShares: 6.67 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $430m-$491m
\nTrade Date: Thursday, 10\/1
\nUnderwriter(s): BofA Securities, Morgan Stanley
\nCo-Manager: Stifel, Wells Fargo Securities, Canaccord Genuity
\nTerms Added: 9-24-20<\/p>\n
\nSymbol: CD
\nDescription: They are the leading carrier-neutral hyperscale data center solution provider in Asia-Pacific emerging markets, focusing on the China, India and Southeast Asia markets.
\nShares: 40 million ADSs
\nPrice Range: $15.00-$17.00
\nMarket Cap: $5.4b-$6.1b
\nTrade Date: Wednesday, 9\/30
\nUnderwriter(s): Morgan Stanley, Citigroup
\nCo-Manager: UBS Investment Bank, China Renaissance
\nTerms Added; 9-23-20<\/p>\n
\nSymbol: ASO
\nDescription: They are one of the leading full-line sporting goods and outdoor recreation retailers in the United States.
\nShares: 15.625 million
\nPrice Range: $15.00-$17.00
\nTrade Date: Friday, 10\/2
\nMarket Cap: $1.32b-$1.5b
\nUnderwriter(s): Credit Suisse, J.P. Morgan, KKR, BofA Securities, Evercore ISI, Guggenheim Securities, UBS Investment Bank, Wells Fargo Securities
\nCo-Manager(s): Stephens Inc., Capital One Securities, Loop Capital Markets, CastleOak Securities, L.P. Blaylock Van, Cabrera Capital Markets, Ramirez & Co., R. Seelaus & Co.
\nTerms Added: 9-23-20<\/p>\n
\nSymbol: YALA
\nDescription: They are the largest voice-centric social networking and entertainment platform in MENA as measured by revenue in 2019, according to the Frost & Sullivan Report.
\nShares: 18.6 million ADSs
\nPrice Range: $7.00-$9.00
\nMarket Cap: $1.0b-$1.3b
\nTrade Date: Wednesday, 9\/30
\nUnderwriter(s): Morgan Stanley, Haitong International
\nCo-Manager: Tiger Global
\nTerms Added: 9-23-20<\/p>\n
\nSymbol: BQ
\nDescription: They are the largest pet-focused platform in China, in terms of revenue in 2019 and number of customers as of December 31, 2019, according to Frost & Sullivan.
\nShares: 7 million ADSs
\nPrice Range: $10.00-$12.00
\nMarket Cap: $907m-$1.1b
\nTrade Date: Week of 9\/28
\nUnderwriter(s):Roth Capital Partners, CMBI, Valuable Capital Limited
\nTerms Added: 9-22-20
\nNote: Each ADSs = 0.75 ordinary shares<\/p>\n
\nSymbol: AVO
\nDescription: They are a world leader in sourcing, producing and distributing fresh avocados, serving retail, wholesale and foodservice customers in over 25 countries.
\nShares: 9.375 million
\nPrice Range: $15.00-$17.00
\nMarket Cap: $1.05b-$1.2b
\nTrade Date: Thursday, October 1
\nUnderwriter(s): BofA Securities, J.P. Morgan, Citigroup
\nCo-Manager: Roth Capital Partners, Stephens Inc., D.A. Davidson & Co.
\nTerms Added: 9-22-20<\/p>\n","protected":false},"excerpt":{"rendered":"